Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Ardelyx discontinues development of RDX-7675

Nov. 22, 2017

Calliditas Therapeutics gives update on phase III study plans for Nefecon

Nov. 21, 2017

FDA extends review period for Tlando NDA

Nov. 20, 2017

Bayer discovers new vasopressin receptor antagonists

Nov. 17, 2017

Investigational mineralocorticoid receptor antagonist KBP-5074 evaluated in phase I trial

Nov. 17, 2017

Achillion reports preliminary data from phase II study of ACH-4471 in C3G

Nov. 15, 2017

TP-0469711 demonstrates promising activity as a new therapeutic for hyperphosphatemia

Nov. 14, 2017

Novel antibody against TGF-beta1 shows efficacy without cardiotoxicity in fibrosis model

Nov. 14, 2017

Wound healing improved with SNF-472 in hemodialysis patients with calciphylaxis

Nov. 13, 2017

FDA accepts Otsuka's resubmitted NDA for tolvaptan

Nov. 10, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...